Explore Cannabinoid receptor 2/CNR2/CB2 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
The cannabinoid delta-9-tetrahydrocannabinol is the principal psychoactive ingredient of marijuana. The proteins encoded by this gene and the cannabinoid receptor 1 (brain) (CNR1) gene have the characteristics of a guanine nucleotide-binding protein (G-protein)-coupled receptor for cannabinoids. They inhibit adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner. These proteins have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. The cannabinoid receptors are members of family 1 of the G-protein-coupled receptors. [provided by RefSeq, Jul 2008]
| Target ID |
GM-T37693
|
| Target Name |
Cannabinoid receptor 2/CNR2/CB2
|
Gene Group ldentifer
（Target Gene ID in Homo
species)
|
1269
|
| Gene ID |
100071536 (Equus caballus), 101100234 (Felis catus), 1269 (Homo sapiens), 12802 (Mus musculus)
539769 (Bos taurus), 57302 (Rattus norvegicus), 612289 (Canis lupus familiaris), 711155 (Macaca mulatta)
|
| Target Alternative Names |
CB-2,CB2,CB2-R,CB2C,CNR2,CNR2C,CX5,Cannabinoid receptor 2,Cnr2,hCB2,rCB2
|
| Uniprot Accession |
P34972,P47936,Q9QZN9
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target, Immuno-oncology Target
|
| Disease from KEGG |
Neuroactive ligand-receptor interaction
|
| Gene Ensembl |
ENSECAG00000005682, ENSG00000188822, ENSMUSG00000062585, ENSBTAG00000019371, ENSCAFG00845014681, ENSMMUG00000004217
|
| Target Classification |
GPCR, Checkpoint-Immuno Oncology
|
Pre-made viral vector of Cannabinoid receptor 2/CNR2/CB2 cDNA Clones/ORF Plasmid
Cannabinoid receptor 2/CNR2/CB2 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo1269 | Pre-made Human CNR2/CB2/CX5 siRNA oligo Duplex | 1269 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo57302 | Pre-made Rat Cnr2/CB2/CB-2 siRNA oligo Duplex | 57302 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo12802 | Pre-made Mouse Cnr2/CB2/CB-2 siRNA oligo Duplex | 12802 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo711155 | Pre-made Cynomolgus/Rhesus macaque CNR2 siRNA oligo Duplex | 711155 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101100234 | Pre-made Cat/Feline CNR2 siRNA oligo Duplex | 101100234 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo612289 | Pre-made Dog/Canine CNR2/CB2 siRNA oligo Duplex | 612289 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo539769 | Pre-made Bovines/Cattle CNR2 siRNA oligo Duplex | 539769 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100071536 | Pre-made Equine/Horse CNR2 siRNA oligo Duplex | 100071536 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
Cannabinoid receptor 2/CNR2/CB2 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T37693-Ab | Human | Anti-Human Cannabinoid receptor 2/CNR2/CB2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T37693-Ab | Rat | Anti-Rat Cannabinoid receptor 2/CNR2/CB2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T37693-Ab | Mouse | Anti-Mouse Cannabinoid receptor 2/CNR2/CB2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T37693-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque Cannabinoid receptor 2/CNR2/CB2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T37693-Ab | Cat/Feline | Anti-Cat/Feline Cannabinoid receptor 2/CNR2/CB2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T37693-Ab | Dog/Canine | Anti-Dog/Canine Cannabinoid receptor 2/CNR2/CB2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T37693-Ab | Bovines/Cattle | Anti-Bovines/Cattle Cannabinoid receptor 2/CNR2/CB2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T37693-Ab | Equine/Horse | Anti-Equine/Horse Cannabinoid receptor 2/CNR2/CB2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
Cannabinoid receptor 2/CNR2/CB2 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T37693-Ag | Human | Human Cannabinoid receptor 2/CNR2/CB2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T37693-Ag | Rat | Rat Cannabinoid receptor 2/CNR2/CB2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T37693-Ag | Mouse | Mouse Cannabinoid receptor 2/CNR2/CB2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T37693-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque Cannabinoid receptor 2/CNR2/CB2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T37693-Ag | Cat/Feline | Cat/Feline Cannabinoid receptor 2/CNR2/CB2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T37693-Ag | Dog/Canine | Dog/Canine Cannabinoid receptor 2/CNR2/CB2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T37693-Ag | Bovines/Cattle | Bovines/Cattle Cannabinoid receptor 2/CNR2/CB2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T37693-Ag | Equine/Horse | Equine/Horse Cannabinoid receptor 2/CNR2/CB2 VLP (virus-like particle) | HEK293 | Products Developing |
